| Collection Name | ClinicalTrials.gov ID | Published on TCIA |
---|
1 | ACRIN-6698 | NCT01564368 | 02 2 May 2022 |
2 | I-SPY2 Trial | NCT01042379 | 02 2 May 2022 |
3 | AREN0532 | NCT00352534 | 31 March 2022 |
4 | AREN0533 | NCT00379340 | 20 January 2022 |
5 | AREN0534 | NCT00945009 | 8 November 2021 |
6 | ACNS0332 | NCT00392327 | 4 May 2021 |
7 | AHEP0731 | NCT00980460 | 30 March 2021 |
8 | CALGB50303 | NCT00118209 | 30 March 2021 |
9 | ACRIN-Contralateral-Breast-MR (ACRIN 6667) | NCT00058058 | 5 March 2021 |
10 | ACRIN-HNSCC-FDG-PET/CT (ACRIN 6685) | NCT00983697 | 13 March 2020 |
11 | ACRIN-DSC-MR-Brain (ACRIN 6677/RTOG 0625) | NCT00433381 | 7 February 2019 |
12 | NSCLC-Cetuximab (RTOG-0617) | NCT00533949 | 15 April 2019 |
13 | ACRIN-NSCLC-FDG-PET (ACRIN 6668) | NCT00083083 | 31 December 2018 |
14 | ACRIN-FMISO-Brain (ACRIN 6684) | NCT00902577 | 12 February 2018 |
15 | ACRIN-FLT-Breast (ACRIN 6688) | NCT00572728 | 11 December 2017 |
16 | ISPY1 (ACRIN 6657) | NCT00043017 | 18 June 2015 |
17 | NRG-1308 (RTOG 1308) | NCT01993810 | 14 September 2015 |
18 | National Lung Screening Trial | NCT00047385 | 1 March 2013 |
19 | Head-Neck Cetuximab (RTOG 0522) | NCT00265941 | 14 November 2013 |
20 | CT Colonography (ACRIN 6664) | NCT00084929 | 15 November 2013 |